SLU-PP-332 benefits are mostly preclinical: mouse studies show fat loss and endurance gains, but no human trials exist. Here's what the data show.
SLU-PP-332 is a synthetic research compound that activates estrogen-related receptors (ERRs), and the benefits documented so far come almost entirely from rodent studies: more fatty acid oxidation, better endurance, and fat loss without a drop in food intake. No human trials of SLU-PP-332 have been published, so claims about what it does in people are extrapolations rather than evidence.
What Is SLU-PP-332?
SLU-PP-332 is a pan-ERR agonist, meaning it binds all three estrogen-related receptor subtypes: ERRα, ERRβ, and ERRγ. Those receptors help control how cells build and run mitochondria, which is why researchers describe the compound as an exercise mimetic. It was developed by scientists at Washington University in St. Louis and studied further at the University of Florida.
It is not a hormone, not a GLP-1 drug, and not a supplement. SLU-PP-332 is a laboratory chemical sold "for research use only," which means no regulator has reviewed it for human dosing, purity, or safety.
The SLU-PP-332 Benefits Reported in Animal Research
Every credible claim about SLU-PP-332 benefits traces back to mice and rats. In diet-induced obese mice, the compound increased fatty acid oxidation, shifted fuel use toward fat, and reduced fat mass even though the animals ate the same amount.
- Fat loss without appetite suppression. Treated mice lost fat mass while food intake stayed flat, which is the opposite of how GLP-1 drugs work.
- Endurance. In one study, treated mice ran roughly 70% farther and about 45% longer than controls.
- Mitochondrial biogenesis. Muscle and liver tissue showed higher expression of genes tied to oxidative metabolism.
- Insulin sensitivity and glucose tolerance. Metabolic markers improved in obese rodent models.
- Cardiac and kidney markers. Some experiments report better heart and kidney function markers in animals with metabolic disease.
| Claimed benefit | Animal evidence | Human evidence |
|---|---|---|
| Fat loss | Reduced fat mass in obese mice | None published |
| Endurance | About 70% greater running distance | None published |
| Mitochondrial density | Upregulated oxidative genes | None published |
| Blood sugar control | Better glucose tolerance in rodents | None published |
SLU-PP-332 Weight Loss: What "Before and After" Posts Leave Out
Searches for slu pp 332 weight loss before and after return forum posts, not trials. The transformations circulating online cannot be verified, and none of them come with bloodwork, dosing records, or a control group. German-language threads on slu pp 332 wirkung ("effect") repeat the same anecdotes in a different language.
The honest summary is that SLU-PP-332 fat loss results in humans are unknown. Mouse data is promising enough to justify further research, but a mouse losing fat over four weeks tells you very little about a 200-pound human taking an unverified capsule.
SLU-PP-332 Dosage Per Day and Bodybuilding Use
There is no established SLU-PP-332 oral dosage per day for humans. The rodent studies used 50 mg/kg, typically given by intraperitoneal injection and sometimes by oral gavage, and no dose-finding study has ever been run in people. That means every slu-pp-332 dosage per day bodybuilding protocol you see online is a guess.
| Setting | Dose and route | What it tells you |
|---|---|---|
| Rodent research | 50 mg/kg, usually injected | Effective in mice and rats |
| Rough human equivalent | About 4 mg/kg (roughly 280 mg for a 70 kg adult) | Math only; no safety data at this dose |
| Vendor suggestion | Often micrograms to a few milligrams orally | Unverified and unstandardized |
Two practical problems make that math unreliable. First, SLU-PP-332 has poor oral bioavailability and low water solubility, so the fraction that reaches your bloodstream from a capsule is unknown. Second, receptor pharmacology often differs between species. For context, the benefits of l carnitine for men are studied in humans at defined doses, which is a much lower bar that most peptides sold online still fail to clear.
How It Compares With Other Compounds People Stack
SLU-PP-332 usually gets discussed alongside fat-loss and recovery compounds. The comparison is uncomfortable, because most of those compounds have at least some human data while SLU-PP-332 has none.
| Compound | Main mechanism | Human data | US legal status |
|---|---|---|---|
| SLU-PP-332 | ERR agonist; exercise mimetic | None published | Research chemical only |
| L-carnitine | Fatty acid transport into mitochondria | Multiple human trials | Legal dietary supplement |
| KPV | Anti-inflammatory tripeptide | Limited; not studied for weight loss | Research chemical |
| BPC-157 | Angiogenesis and tissue repair | Very limited in the US | Not FDA-approved |
If you are weighing metabolic options, it is fair to ask does kpv help with weight loss; the answer is that KPV is studied for inflammation, not fat oxidation, and human weight-loss data is essentially absent. The same caution applies on the recovery side, where people ask does bpc-157 help with muscle growth even though US human evidence remains thin.
Prescription drugs come with FDA labeling that spells out accepted uses, documented vyleesi side effects, and a published vyleesi cost. SLU-PP-332 has none of that transparency, which is the single biggest difference between a research chemical and a real medicine.
Safety, Sourcing, and Legal Status
SLU-PP-332 is not FDA-approved for human use in the United States. It is sold as a research chemical, which means purity, identity, and sterility are not guaranteed by any regulator, and certificates of analysis are easy to counterfeit.
There is also a biological reason for caution. ERRα and ERRγ influence gene expression in many tissues, including some linked to cancer biology in certain contexts. Turning those receptors on continuously for months has never been studied in humans, so long-term risk is unknown. Anyone considering a research peptide should speak with a licensed healthcare professional first, and baseline bloodwork is not optional.
Bottom Line on SLU-PP-332 Benefits
SLU-PP-332 benefits are well documented in mice and completely unproven in humans. As of this writing, SLU-PP-332 has not been tested in a single published human trial. Dosage numbers circulating in weight loss reviews online are anecdotal, not clinical. For fat loss, calorie control, resistance training, and clinically validated options still have far more evidence behind them.
Frequently Asked Questions
Does SLU-PP-332 actually work for weight loss in humans?
No human trial of SLU-PP-332 has been published, so its effect on human weight loss is unproven. In obese mice, the compound reduced fat mass and increased fatty acid oxidation without changing food intake. Mouse metabolism frequently fails to translate to people, so the human result is genuinely unknown.
What SLU-PP-332 dosage do bodybuilders use?
There is no established human dose of SLU-PP-332. Rodent studies used 50 mg/kg, usually by injection, which converts to roughly 280 mg for a 70 kg adult, but that math ignores poor oral bioavailability and species differences. Vendor suggestions vary widely and come with no safety data.
Is SLU-PP-332 safe or legal in the United States?
SLU-PP-332 is not FDA-approved for human use and is sold strictly for laboratory research. No human safety, toxicity, or long-term data exist, and estrogen-related receptors influence gene expression in many tissues. Talk to a healthcare professional before using any unapproved research peptide.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.